Related Experiment Video
Updated: Jun 13, 2026

High-throughput Functional Screening using a Homemade Dual-glow Luciferase Assay
Published on: June 1, 2014
Overexpression of alpha-synuclein down-regulates BDNF expression.
Yuhe Yuan1, Jiandong Sun, Ming Zhao
1Key Laboratory of Bioactive Substances and Resources Utilization, Ministry of Education, Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, People's Republic of China.
Alpha-synuclein overexpression in Parkinson's disease (PD) reduces brain-derived neurotrophic factor (BDNF) by disrupting signaling pathways. This study elucidates a key mechanism in PD pathogenesis involving alpha-synuclein and BDNF.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Parkinson's disease (PD) involves the loss of dopaminergic neurons.
- The precise molecular mechanisms driving this degeneration remain unclear.
- Reduced brain-derived neurotrophic factor (BDNF) is implicated in PD pathogenesis.
Purpose of the Study:
- To investigate the role of alpha-synuclein in regulating BDNF expression in PD.
- To elucidate the molecular pathways affected by alpha-synuclein in dopaminergic neurons.
Main Methods:
- Overexpression of alpha-synuclein in a cellular model.
- Analysis of BDNF expression levels.
- Assessment of transcriptional factors (NFAT, CREB) activity.
- Investigation of protein kinase C (PKC) signaling pathway components (GSK3beta, ERK).
Main Results:
- Alpha-synuclein overexpression decreased BDNF expression.
- Suppressed transactivation of NFAT and CREB, key regulators of BDNF.
- Impaired protein kinase C (PKC) activity and altered downstream signaling (activated GSK3beta, inhibited ERK).
Conclusions:
- Alpha-synuclein disrupts BDNF regulation through the PKC signaling pathway.
- This impairment may contribute to dopaminergic neuron degeneration in Parkinson's disease.
- Understanding this mechanism offers potential therapeutic targets for PD.
More Related Videos
Related Concept Videos
Neural Regulation
Drugs Affecting Neurotransmitter Synthesis
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Parkinson Disease ll: Pathophysiology

